Robert Stanton, MD
https://reachmd.com/profiles/robert-stanton-md/L8b8xj/
Dr. Robert Stanton is an Associate Professor of Medicine at Harvard Medical School. Dr. Stanton is both a scientist and clinical physician in his roles as principal Investigator in the Section on Vascular Cell Biology and as the Chief of Nephrology at Joslin Clinic.
Bora Lim, M.D.
https://reachmd.com/profiles/bora-lim-md/7rJEDa/
Bora Lim, MD, is an Assistant Professor of Breast Medical Oncology in the Section of Translational Breast Cancer Research at the University of Texas MD Anderson Cancer Center. She is a translational investigator researching novel therapeutic strategies to halt or treat aggressive breast cancer by a…
Immuno-Oncology (IO) Updates - Programs
https://reachmd.com/programs/immuno-oncology-io-updates/
Keep up-to-date on the latest management options for all cancer types, including: non-small cell lung cancer, head and neck, and more! This series provides an overview of efficacy and safety of strategies targeting the immune system, including the use of immune-modifying agents, and immune checkpoi…
David S. Pisetsky, MD, PhD
https://reachmd.com/profiles/david-s-pisetsky-md-phd/O9PQzG/
David Pisetsky, MD, PhD is Professor of Medicine and Immunology, Duke University Medical Center and Chief of Rheumatology, Durham Veterans Administration Medical Center. He received his BA from Harvard College magna cum laude in 1967 and his PhD and MD degrees from the Albert Einstein College of Me…
Andrew D. Badley, MD, FRCP(C), FACP, FIDSA
https://reachmd.com/profiles/andrew-d-badley-md-frcpc-facp-fidsa/LkE6Wd/
Andrew D. Badley, MD, is Professor of Medicine in the Division of Infectious Diseases and HH Sheikh Khalifa Bin Zayed Al-Nahyan Professor of Infectious Diseases at the Mayo Clinic in Rochester, Minnesota. He received his medical degree from Dalhousie University in Halifax, Nova Scotia, Canada, befo…
Closing the Gaps in NSCLC - Programs
https://reachmd.com/programs/closing-gaps-nsclc/
Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lackin…
Robert Vonderheide, MD
https://reachmd.com/profiles/robert-vonderheide-md/L8e0Dy/
Robert Vonderheide, MD, DPhil, an internationally renowned cancer immunotherapy and translational research expert, has been named Director of the Abramson Cancer Center of the University of Pennsylvania. He is the Hanna Wise Professor in Cancer Research at the Perelman School of Medicine, Vice Cha…
Jean Hoffman-Censits, MD
https://reachmd.com/profiles/jean-hoffman-censits-md/La3EAJ/
Dr. Jean Hoffman-Censits is an Assistant Professor at the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia. She is Director of the Multidisciplinary Genitourinary Oncology Center. Dr. Hoffman-Censits’ clinical focus is on urologic malignancies, specifically urothelial and prosta…
Harry Paul Erba, MD, PhD
https://reachmd.com/profiles/harry-paul-erba-md-phd/O9PJZR/
I am a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine. I serve as Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies. I am also the Chair of the SWOG Leukemia Committee. I am inter…
Philip McCarthy, Jr, MD
https://reachmd.com/profiles/philip-mccarthy-jr-md/7ZDk9Q/
Philip McCarthy Jr, MD, is a Professor of Oncology and the Director of the Blood and Marrow Transplantation (BMT) Program at Roswell Park Cancer Institute (RPCI). He has been a BMT physician and hematologist/oncologist since finishing fellowship training in 1989 and has been the BMT director at RPC…